Letters to the Editor

Abstract

Get full access to this article

View all access options for this article.

References

Hendry

Campbell

A.M.

Campbell

Antithrombotic therapy prescribed for patients with non-rheumatic atrial fibrillation. Scot Med J 1994: 39; 110–111.

Atrial fibrillation investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Archives of Internal Medicine 1994: 154; 1449–1457.

Hylek

E.M.

Singer

D.E.

Risk factors for intracranial hemorrhage in out patients taking warfarin. Annals of Internal Medicine 1994: 120; 897–902.

Stroke prevention in atrial fibrillation investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke prevention in atrial fibrillation II. Lancet 1994: 343; 687–691.

Ezekowitz

M.D.

Bridgers

S.L.

Janes

K.E.

Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. New England Journal of Medicine 1992: 327; 1406–1412.

European Atrila Fibrillation Trial Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1994: 342; 1255–1262.

Hendry

Campbell

MacDonald

Williams

. Antithrombotic therapy prescribed for patients with non-rheumatic atrial fibrillation. Scot Med J 1994; 39: 110–111.

Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation 11 Study. Lancet 1994; 343: 687–91.

Stroke Prevention in Atrial Fibrillation Investigators. Predicting thromboembolism in atrial fibrillation, I: Clinical features of patients at risk. Ann Intern Med 1992: 116: 1–5.

10.

Stroke Prevention in Atrial Fibrillation Investigators. Predicting thromboembolism in atrial fibrillation, II: Echocardiographic features of patients at risk. Ann Intern Med 1992; 116: 6–12.

11.

EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255–62.